Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Autoimmune Disorders

Free Subscription 06.06.2022 1 Acta Neurol Scand 1 Brain 1 Diabetes 5 J Neurol 2 J Rheumatol 2 Mult Scler 1 Nat Rev Neurol 1 Neurologia (Engl Ed) 3 PLoS One 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neurol Scand

1. HAYAT S, Asad A, Hasan I, Jahan I, et al
   Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barre syndrome.
   Acta Neurol Scand. 2022 Jun 2. doi: 10.1111/ane.13649.
   PubMed         Abstract available
   
   

   
   Brain

2. MADSEN MAJ, Wiggermann V, Marques MFM, Lundell H, et al
   Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7 T MRI study.
   Brain. 2022 Jun 2. pii: 6599027. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabetes

3. LIN Y, Perovanovic J, Kong Y, Igyarto BZ, et al
   Antibody-Mediated Targeting of a Hybrid-Insulin-Peptide Towards Neonatal Thymic Langerin+ Cells Enhances T Cell Central Tolerance and Delays Autoimmune Diabetes.
   Diabetes. 2022 May 27. pii: 147050. doi: 10.2337/db21-1069.
   PubMed         Abstract available
   
   

   
   J Neurol

4. DORCET G, Migne H, Biotti D, Bost C, et al
   Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression.
   J Neurol. 2022 Jun 2. pii: 10.1007/s00415-022-11197.
   PubMed         Abstract available
   
   
5. MISCIOSCIA A, Puthenparampil M, Miante S, Pengo M, et al
   Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.
   J Neurol. 2022 Jun 1. pii: 10.1007/s00415-022-11183.
   PubMed         Abstract available
   
   
6. HRASTELJ J, Robertson NP
   A role for the Epstein-Barr virus in multiple sclerosis aetiology?
   J Neurol. 2022 May 31. pii: 10.1007/s00415-022-11177.
   PubMed        
   
   
7. GOLD R, Piani-Meier D, Kappos L, Bar-Or A, et al
   Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study.
   J Neurol. 2022 May 31. pii: 10.1007/s00415-022-11166.
   PubMed         Abstract available
   
   
8. JARIUS S, Komorowski L, Regula JU, Haas J, et al
   Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
   J Neurol. 2022 May 27. pii: 10.1007/s00415-022-11178.
   PubMed         Abstract available
   
   

   
   J Rheumatol

9. ROSS C, Elfassy HL, Makhzoum JP
   Somatic Mutation in UBA1 and ANCA-associated Vasculitis.
   J Rheumatol. 2021;48:1626-1627.
   PubMed        
   
   
10. SIMONS G, Falahee M
    Fear of the Unknown: Can We Help Individuals With a Systemic Autoimmune Rheumatic Disease Deal With Uncertainty?
    J Rheumatol. 2022 Jun 1. pii: jrheum.220502. doi: 10.3899/jrheum.220502.
    PubMed         Abstract available
    
    

    
    Mult Scler

11. BEREK K, Hegen H, Hocher J, Auer M, et al
    Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.
    Mult Scler. 2022 Jun 2:13524585221097566. doi: 10.1177/13524585221097566.
    PubMed         Abstract available
    
    
12. KANINIA S, Grammatikos A, Urankar K, Renowden SA, et al
    CNS demyelination associated with immune dysregulation and a novel CTLA-4 variant.
    Mult Scler. 2021;27:1464-1467.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

13. FYFE I
    Ageing reduces potential for remyelination in multiple sclerosis.
    Nat Rev Neurol. 2022 May 31. pii: 10.1038/s41582-022-00680.
    PubMed        
    
    

    
    Neurologia (Engl Ed)

14. DIAZ-MAROTO I, Garcia-Garcia J, Sanchez-Ayaso PA, Alcahut-Rodriguez C, et al
    Ocular myasthenia gravis and risk factors for developing a secondary generalisation: description of a Spanish series.
    Neurologia (Engl Ed). 2022 May 27. pii: S2173-5808(22)00053.
    PubMed         Abstract available
    
    

    
    PLoS One

15. COYNE MJ, Schultze AE, McCrann DJ 3rd, Murphy RE, et al
    Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
    PLoS One. 2022;17:e0269085.
    PubMed         Abstract available
    
    
16. ELKHALII-WILHELM S, Sippel A, Riemann-Lorenz K, Kofahl C, et al
    Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.
    PLoS One. 2022;17:e0268988.
    PubMed         Abstract available
    
    
17. KOFFMAN J, Penfold C, Cottrell L, Farsides B, et al
    "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.
    PLoS One. 2022;17:e0265861.
    PubMed         Abstract available
    
    

    
    Thyroid

18. HOU X, Guan H, Sun S, Shi Y, et al
    Outcomes of Early-pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-up Study.
    Thyroid. 2022 Jun 1. doi: 10.1089/thy.2022.0088.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: